Schneider R - Search Results

1

Bruton's Tyrosine Kinase Inhibition in Multiple Sclerosis.

Schneider R, Oh J. Schneider R, et al. Curr Neurol Neurosci Rep. 2022 Nov;22(11):721-734. doi: 10.1007/s11910-022-01229-z. Epub 2022 Oct 27. Curr Neurol Neurosci Rep. 2022. PMID: 36301434 Free PMC article. Review.

2

Vitamin D as disease-modifying therapy for multiple sclerosis?

Lincoln MR, Schneider R, Oh J. Lincoln MR, et al. Among authors: schneider r. Expert Rev Clin Immunol. 2021 Jul;17(7):691-693. doi: 10.1080/1744666X.2021.1915772. Epub 2021 Apr 15. Expert Rev Clin Immunol. 2021. PMID: 33836645 No abstract available.

3

Clinical characteristics and outcomes of multiple sclerosis patients with COVID-19 in Toronto, Canada.

Solomon JM, Jones A, Hohol M, Krysko KM, Muccilli A, Roll A, Rotstein D, Schneider R, Selchen D, Vosoughi R, Baral SD, Oh J. Solomon JM, et al. Among authors: schneider r. Mult Scler Relat Disord. 2022 Feb;58:103509. doi: 10.1016/j.msard.2022.103509. Epub 2022 Jan 8. Mult Scler Relat Disord. 2022. PMID: 35030366 Free PMC article.

4

A Birth Year Cohort and What It Can Reveal About Lipid Mediators as Putative Biomarkers of Progression in Multiple Sclerosis.

Rotstein D, Schneider R. Rotstein D, et al. Among authors: schneider r. Neurology. 2023 Aug 1;101(5):197-198. doi: 10.1212/WNL.0000000000207605. Epub 2023 Jun 8. Neurology. 2023. PMID: 37290973 No abstract available.

5

GM-CSF is a marker of compartmentalised intrathecal inflammation in multiple sclerosis.

Martin SJ, Brand-Arzamendi K, Saab G, Muccilli A, Oh J, Schneider R. Martin SJ, et al. Among authors: schneider r. Mult Scler. 2023 Oct;29(11-12):1373-1382. doi: 10.1177/13524585231195861. Epub 2023 Sep 12. Mult Scler. 2023. PMID: 37700482

6

Multiple sclerosis and exercise-A disease-modifying intervention of mice or men?

Martin SJ, Schneider R. Martin SJ, et al. Among authors: schneider r. Front Neurol. 2023 Oct 10;14:1190208. doi: 10.3389/fneur.2023.1190208. eCollection 2023. Front Neurol. 2023. PMID: 37885474 Free PMC article. Review.

7

Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis.

Chertcoff A, Schneider R, Azevedo CJ, Sicotte N, Oh J. Chertcoff A, et al. Among authors: schneider r. Neurol Clin. 2024 Feb;42(1):15-38. doi: 10.1016/j.ncl.2023.06.008. Epub 2023 Aug 5. Neurol Clin. 2024. PMID: 37980112 Review.

8

Plasma glial fibrillary acidic protein levels correlate with paramagnetic rim lesions in people with radiologically isolated syndrome.

Schneider R, Brand-Arzamendi K, Reynold Lim T, Lee LE, Guenette M, Suthiphosuwan S, Bharatha A, Oh J. Schneider R, et al. Mult Scler. 2024 Feb;30(2):156-165. doi: 10.1177/13524585231219131. Epub 2023 Dec 25. Mult Scler. 2024. PMID: 38145319

9

Autoantibodies to Potassium Channel KIR4.1 in Multiple Sclerosis.

Schneider R. Schneider R. Front Neurol. 2013 Sep 2;4:125. doi: 10.3389/fneur.2013.00125. eCollection 2013. Front Neurol. 2013. PMID: 24032025 Free PMC article. No abstract available.

10

Eosinophilic CNS vasculitis can mimic demyelinating disease of the brain and spinal cord.

Schneider R, Tsai JP, Munoz DG, Selchen DH. Schneider R, et al. Neurology. 2015 Feb 3;84(5):543-4. doi: 10.1212/WNL.0000000000001203. Neurology. 2015. PMID: 25646272 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,873 results

Search Page